SELENOO and chronic obstructive pulmonary disease: At p-value<0.05, methylation levels of the promoter regions of 3 of the 126 key regulators in COPD groups, ACSF3, SELO, and EPAS1, significantly correlated with all 5 disease severity phenotypes (Fig. 4A; S10 Table).